Evogene to Participate at Piper Jaffray Global Agriculture Symposium01/08/2016
- Company COO to discuss the disruptive potential of genome editing on classical breeding pipelines -
Rehovot, Israel – August 1, 2016 – Evogene Ltd. (NYSE; TASE: EVGN), a leading biotechnology company for the improvement of crop productivity for the food, feed and fuel industries, announced today that Assaf Kacen, Chief Operating Officer, will participate at the Piper Jaffray Global Agriculture Symposium taking place in Minneapolis, Minnesota, August 2, 2016.
Mr. Kacen will take part at the Gene Editing panel which will take place on Tuesday, August 2, at 2:00 pm. He will discuss the potential of genome editing to significantly impact traditional breeding pipelines, and the potential effect of the disruptive technology on the expansion of Evogene's business offering.
Investors or potential partners attending the conference, who wish to meet with Mr. Kacen, may contact Evogene’s Investor Relations team at email@example.com.
About Evogene Ltd.:
Evogene (NYSE, TASE: EVGN) is a leading biotechnology company for the improvement of crop productivity for the food, feed and fuel industries. The Company operates in three key market segments: improved seed traits (addressing yield and resistance to diseases and environmental stresses); innovative ag-chemicals (developing novel herbicide solutions for weed control); and ag-biologicals. Evogene has collaborations with world-leading seed and ag-chemical companies. For more information, please visit www.evogene.com or contact the Company at firstname.lastname@example.org.
This press release contains "forward-looking statements" relating to future events. These statements may be identified by words such as "may", "could", “expects”, "intends", “anticipates”, “plans”, “believes”, “scheduled”, “estimates” or words of similar meaning. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which beyond Evogene's control, including, without limitation, those risk factors contained in Evogene’s reports filed with the appropriate securities authority. Evogene disclaims any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.
Press releases for 2016
- Evogene Reports First Quarter 2017 Financial Results
- Evogene Financial Results for the First Quarter of 2017 Earnings Announcement Schedule
- Marrone Bio Innovations and Evogene Advance Novel Bacteria and Related Proteins Beyond Discovery into Insecticidal Product Development Phase
- Evogene to Present Innovative Approach for Improving Cannabis for Medical Needs at CannaTech Summit
- Evogene Reports Fourth Quarter and Full Year 2016 Financial Results
- Evogene and ICL Innovation Sign Collaboration for Development of Crop Enhancers
- Evogene Fourth Quarter and Full Year 2016 Earnings Announcement Schedule
- Evogene to Transfer Stock Exchange Listing to Nasdaq
- Evogene Reports Third Quarter 2016 Financial Results
- Evogene Announces Positive Field Trial Results in Ag-biologicals Program
- Evogene Third Quarter 2016 Earnings Announcement Schedule
- Evogene and IMAmt Sign Collaboration for Genomic Promoter Discovery and Validation in Cotton
- Evogene Announces Joint Microbial Diversity Activity with University of Missouri
- Evogene Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
- Evogene Appoints a New Member to Board of Directors and a New Chief Operating Officer
- Evogene Reports Second Quarter 2016 Financial Results
- Evogene to Participate at Piper Jaffray Global Agriculture Symposium
- Evogene Second Quarter 2016 Earnings Announcement Schedule
- Evogene to Present at Crops and Chemicals 2016 Conference
- Evogene Reports Financial Results for the First Quarter of 2016
- Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
- Evogene to Present the Potential of Integrating Novel Genome Editing Technology with its Core Capabilities for Improved Seed Traits at Plant Genomics Congress
- Evogene’s First Quarter 2016 Earnings Announcement Schedule
- Evogene Files Annual Report for the Year Ended December 31, 2015
- Evogene Selected for Photosynthesis Research Consortium within European Horizon 2020 Program
- Evogene Reports Fourth Quarter and Full Year 2015 Financial Results
- Evogene Discloses Positive Results in Yield Improvement Collaboration with Monsanto Utilizing Novel 'Trait-First' Methodology
- Evogenes Fourth Quarter with Full Year 2015 Earnings Announcement Schedule